Experimental therapy gantenerumab fails to slow or improve Alzheimer's memory loss in clinical trials

2 years ago 1

An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer's or those who were in the early phases of the disease, the manufacturer said Monday.

*** Disclaimer: This Article is auto-aggregated by a Rss Api Program and has not been created or edited by Nandigram Times

(Note: This is an unedited and auto-generated story from Syndicated News Rss Api. News.nandigramtimes.com Staff may not have modified or edited the content body.

Please visit the Source Website that deserves the credit and responsibility for creating this content.)

Watch Live | Source Article